CVE-2024-11814

Additional Custom Order Status for WooCommerce <= 1.6.0 - Reflected Cross-Site Scripting

Description

The Additional Custom Order Status for WooCommerce plugin for WordPress is vulnerable to Reflected Cross-Site Scripting via the wfwp_wcos_delete_finished, wfwp_wcos_delete_fallback_finished, wfwp_wcos_delete_fallback_orders_updated, and wfwp_wcos_delete_fallback_status parameters in all versions up to, and including, 1.6.0 due to insufficient input sanitization and output escaping. This makes it possible for unauthenticated attackers to inject arbitrary web scripts in pages that execute if they can successfully trick a user into performing an action such as clicking on a link.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.11%
Affected: algoritmika Additional Custom Order Status for WooCommerce
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-11814?
CVE-2024-11814 has been scored as a medium severity vulnerability.
How to fix CVE-2024-11814?
To fix CVE-2024-11814, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-11814 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-11814 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-11814?
CVE-2024-11814 affects algoritmika Additional Custom Order Status for WooCommerce.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.